Trial Profile
A randomised, double-blind, placebo- and active-controlled, parallel-arm, multicentre study to assess efficacy, pharmacokinetics, safety and tolerability of multiple dose levels of abediterol administered once daily for four weeks, in patients with asthma symptomatic on inhaled corticosteroids
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Jun 2019
Price :
$35
*
At a glance
- Drugs Abediterol (Primary) ; Salmeterol
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 18 Apr 2019 This trial has been completed in Hungary, according to European Clinical Trials Database.
- 16 Dec 2017 Status changed from not stated to recruiting.
- 07 Sep 2017 New trial record